Skip to main content
Journal ArticleOPEN ACCESS

Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes

Cochrane Database of Systematic Reviews (2023) 2023(4)
DOI: 10.1002/14651858.CD015849
0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. This review aims to assess the benefits and harms of GLP-1 receptor agonists to treat diabetes in people with CKD.

Cite

CITATION STYLE

APA

Natale, P., Palmer, S. C., Tunnicliffe, D. J., Toyama, T., & Strippoli, G. F. M. (2023). Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes. Cochrane Database of Systematic Reviews, 2023(4). https://doi.org/10.1002/14651858.CD015849

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free